Every national program, government benefit, and community resource that provides a free or no-cost PSA test — with direct contact information for each one.
Prostate cancer is the most commonly diagnosed non-skin cancer in American men. The American Urological Association’s latest 2026 guidelines project 333,830 new diagnoses and 36,320 deaths in the United States this year alone. The PSA (Prostate-Specific Antigen) blood test is the primary early detection tool — and for many men, accessing it costs nothing. Here is what the science and guidelines actually say.
- 1 Medicare pays 100% for a PSA blood test every 12 months for men over 50. Medicare Part B covers a PSA blood test annually — at zero cost to you. No deductible. No coinsurance. No copay. The one condition: your doctor or provider must accept Medicare assignment. This benefit begins the day after your 50th birthday and applies to all Medicare beneficiaries, including those under 65 who qualify due to disability. This is the single most accessible free PSA test available to older American men.
- 2 Prostate cancer is the second leading cause of cancer death in American men. According to the National Cancer Institute’s SEER data, prostate cancer accounts for 30 percent of all cancers in men and 11 percent of cancer-related deaths. Approximately 1 in 8 men will receive a prostate cancer diagnosis during their lifetime. The five-year survival rate for localized prostate cancer caught early is 97.9 percent — compared to significantly lower survival rates when caught at an advanced stage.
- 3 Black men face disproportionately higher risk and should begin screening sooner. Age-adjusted prostate cancer mortality rates for Black men are 36.4 per 100,000 — more than double the rate for white men at 17.9 per 100,000, according to NCI SEER data from 2022. ZERO Cancer reports that every 18 minutes, a Black man in the United States is diagnosed with prostate cancer. The AUA’s 2026 guidelines specifically recommend that Black men and others at elevated risk begin PSA discussions between ages 40 and 45 — five to ten years earlier than average-risk men.
- 4 An elevated PSA does not mean you have cancer. PSA can be elevated by benign prostatic hyperplasia (an enlarged prostate), prostatitis (prostate inflammation), certain medications, recent ejaculation, vigorous cycling, or a prostate biopsy. More than 15 percent of men who undergo regular screening will experience at least one false-positive result over 10 years, according to randomized clinical trial data reviewed by the USPSTF. A positive PSA test result means additional evaluation is needed — not a cancer diagnosis.
- 5 The AUA’s new 2026 guidelines shift toward earlier and more personalized screening. The American Urological Association’s 2026 Early Detection of Prostate Cancer guideline now recommends clinicians offer baseline PSA screening to average-risk men ages 45 to 50, with higher-risk men (Black men, those with germline mutations, or those with a strong family history) starting at 40 to 45. Regular screening every 2 to 4 years is recommended from ages 50 to 69. This reflects updated evidence and represents a more proactive stance than previous guidelines.
- 6 Veterans receive free PSA tests through the VA healthcare system. Veterans enrolled in VA healthcare receive prostate cancer screening as a covered preventive service — at no cost. Veterans who developed prostate cancer following exposure to Agent Orange or other herbicides during military service do not need to prove a service connection: they are automatically eligible for VA health care and disability compensation under current law. Contact your local VA medical center or call the VA at 1-800-827-1000 to establish eligibility.
- 7 Federally Qualified Health Centers offer free or sliding-scale PSA testing to uninsured men. The federal government’s Health Resources and Services Administration (HRSA) funds over 1,400 Federally Qualified Health Centers (FQHCs) across all 50 states. These community health clinics provide PSA testing and follow-up care on a sliding fee scale based on income — and for those below the poverty line, services are provided regardless of ability to pay. No insurance required. Use the HRSA locator at findahealthcenter.hrsa.gov to find the nearest clinic.
- 8 ZERO Cancer maintains a national searchable database of free PSA testing sites. ZERO Prostate Cancer — the nation’s leading prostate cancer nonprofit, founded in 1996 — maintains an active online database of free and low-cost PSA testing sites and events searchable by ZIP code at zerocancer.org. Each listing shows location, eligibility requirements, and contact information. If no site appears near you, ZERO advises that there may still be nearby options that are not yet listed — contact them directly for assistance.
- 9 Avoid certain activities before your PSA test for accurate results. To ensure your PSA result accurately reflects your prostate health, avoid ejaculation for 48 hours before the test, avoid vigorous exercise (especially cycling) for 48 hours before, avoid a digital rectal exam (DRE) for at least one week before the test, and avoid a prostate biopsy for at least six weeks before. Certain medications including finasteride (Proscar, Propecia) and dutasteride (Avodart) artificially lower PSA levels — inform your doctor of all medications before testing.
- 10 Community health fairs, churches, and mobile health units bring free PSA tests to underserved neighborhoods. Research published in PMC (PubMed Central) documenting community-based PSA screening programs found that offering free prostate screening in community settings is an effective method of reaching men who would otherwise not be tested — with 4 out of 150 participants diagnosed with prostate cancer who may not have been detected otherwise. Local churches, barbershops, community health fairs, and mobile health units operated by academic medical centers all provide testing in neighborhoods with limited healthcare access.
Sources: AUA Early Detection of Prostate Cancer Guideline 2026 — AUAnet.org (333,830 projected 2026 cases; 36,320 projected deaths; screening age recommendations by risk). NCI SEER / cancer.gov (prostate cancer mortality rates; 5-year survival 97.9%; 30% of male cancers). AARP/Medicare.gov Nov 2025 (Medicare Part B free PSA; no cost-sharing). ZERO Cancer 2026 (Black men every 18 min; national database). VA.gov/cancer.va.gov (veterans free PSA; Cleland-Dole Act; Agent Orange automatic eligibility). HRSA.gov / findahealthcenter.hrsa.gov (FQHCs; sliding fee scale). USPSTF (false positive 15% over 10 years; PSA harms and benefits). Mayo Clinic / StatPearls NCBI 2026 (pre-test preparation instructions). PMC community-based screening study (4/150 diagnosed; effectiveness).
Sources: AUA 2026 Early Detection Guideline (new cases); NCI SEER 2022 (mortality rates; 5-year survival); ACS (1-in-8 lifetime risk); Medicare.gov 2026 (zero cost PSA benefit).
Free screening events are time-limited and scheduling changes frequently. Always call or check the organization’s website to confirm current availability, eligibility requirements, and appointment times before traveling to any location. Contact information below was verified in March 2026. Some programs have geographic eligibility requirements.
Sources: Medicare.gov 2026 (Part B PSA free benefit; DRE coinsurance). VA.gov / cancer.va.gov (veteran eligibility; Cleland-Dole Act 2022; 1-800-827-1000). ZERO Cancer / zerocancer.org (national database; Run/Walk events; 10,000+ Black men screened; MENtor program; 1-844-244-1309). HRSA.gov / findahealthcenter.hrsa.gov (FQHC locator; 1-400 sites; sliding fee scale). GW Cancer Center confirmed 2026 (202-741-3121; 202-677-6962; monthly 4th Friday). PCF.org (1-800-757-2873; community events). Mount Sinai Urology (212-241-4812; EDDY mobile; Harlem/Queens). Roswell Park / roswellpark.org (1-877-275-7724; EDDY mobile NY). Howard University Cancer Center (202-865-6100; Men Take Ten; ages 40-75). NJ CEED (800-328-3838; 609-465-1047 English; 609-465-6840 Spanish). ACS (1-800-227-2345; 24/7). CDC.gov/cancer (state program locator). NBC4 Washington Sept 2025 (Men Take Ten; GW Cancer Center resources). PMC community-based PSA study (4/150 diagnosed; church outreach effectiveness).
| Resource | Who Qualifies | Cost | How to Access |
|---|---|---|---|
| Medicare Part B | All Medicare beneficiaries, men 50+ | $0 (PSA only) | Ask your doctor; confirm provider accepts Medicare assignment |
| VA Healthcare | Enrolled veterans; Agent Orange exposure = automatic | Free | va.gov/find-locations or call 1-800-827-1000 |
| HRSA / FQHCs | Uninsured or low-income, all men | Free to sliding scale | findahealthcenter.hrsa.gov |
| GW Cancer Center | Men 40–70, no prior prostate cancer, DC area | Free | (202) 741-3121 — appointment required |
| NJ CEED | Uninsured NJ residents; some insured eligible | Free | (800) 328-3838 |
| ZERO Cancer Events | All men — event-based eligibility varies | Free at events | zerocancer.org locator or 1-844-244-1309 |
| ACS Referral Line | All men — referral to local programs | Free referral service | 1-800-227-2345 (24/7) |
| State Health Dept. | Low-income, uninsured; varies by state | Free to low-cost | cdc.gov/cancer or your county health dept. |
Sources: All contact information and eligibility verified from respective official sources, March 2026. Eligibility requirements subject to change — always verify directly with the program before visiting.
PSA levels can be temporarily elevated by entirely normal activities — not just prostate problems. Failing to follow pre-test guidelines can lead to a falsely elevated PSA result, triggering unnecessary worry, additional tests, and potentially an unneeded biopsy. Follow these steps carefully before every PSA test.
Sources: StatPearls / NCBI 2026 (pre-test preparation; ejaculation; exercise; biopsy timing). Mayo Clinic (DRE before PSA draw; drug effects on PSA). NCBI / PMC (finasteride PSA suppression ~50%; saw palmetto effects). AUA 2026 Guideline (repeat PSA before biopsy; test interpretation).
The traditional general threshold of 4.0 ng/mL (nanograms per milliliter) was historically used as the cutoff for concern, but the American Urological Association’s 2026 guideline has moved away from a single number toward age-adjusted ranges and additional biomarkers.
As a general orientation, PSA levels by age are approximately: under 2.5 ng/mL for men under 50; under 3.5 ng/mL for men 50–59; under 4.5 ng/mL for men 60–69; and under 6.5 ng/mL for men 70 and older. These are orientational, not diagnostic — your doctor interprets your result in context of your age, race, family history, prostate size, and prior PSA trends.
An elevated PSA does not diagnose cancer. PSA can be elevated by benign prostatic hyperplasia (enlarged prostate), prostatitis (prostate inflammation), urinary tract infections, recent sexual activity, vigorous cycling, or a recent prostate examination. An elevated result means additional evaluation is warranted, not that cancer is present. Research from the PLCO Cancer Screening Trial published in PubMed found that adding percent free PSA measurement to total PSA significantly improved prediction of clinically significant prostate cancer and should be used to reduce unnecessary biopsies.
This is genuinely debated among major medical organizations, and current guidance varies. The USPSTF recommends against routine PSA screening for men 70 and older, citing evidence from randomized clinical trials showing no reduction in prostate cancer mortality from screening in this age group, combined with increased risks from false positives, biopsies, and potential overtreatment. The USPSTF’s current guidance is under reassessment as of 2026, per AARP reporting.
The AUA’s 2026 guideline takes a more individualized approach — recommending that screening decisions for older men be personalized based on overall health, life expectancy, patient values and preferences, and shared decision-making between the man and his physician rather than a blanket age cutoff.
Medicare continues to cover the free annual PSA test regardless of age — Medicare itself imposes no upper age limit on PSA coverage. The decision about whether to use that benefit should be made through a conversation with your primary care physician that weighs your personal health status, family history, and preferences about early detection versus the potential harms of overdiagnosis and treatment. There is no single right answer for all men over 70.
An elevated PSA result begins a process of further evaluation — it does not trigger immediate treatment or surgery. The AUA’s 2026 guideline specifically recommends that physicians repeat the PSA test before proceeding to any secondary biomarker, imaging, or biopsy — a single elevated result can be caused by transient factors and should be confirmed.
If the repeat PSA remains elevated, next steps typically include a more detailed evaluation using additional biomarkers — such as percent free PSA, the Prostate Health Index (PHI), or the 4Kscore — which help differentiate between benign causes and clinically significant cancer risk without immediately proceeding to biopsy.
If biomarker results suggest higher risk, your physician may order a multiparametric MRI (mpMRI) of the prostate — a significantly improved imaging tool that has become standard practice and can help identify whether a biopsy is necessary and, if so, where to target it. Only after this evaluation pathway would a prostate biopsy typically be recommended. The days of a single PSA result leading directly to a biopsy are largely behind us in modern urological practice.
Several pathways exist specifically for uninsured men. The most direct is a Federally Qualified Health Center (FQHC). FQHCs are federally mandated to provide care regardless of ability to pay — PSA testing is included. You can find the nearest FQHC using the HRSA locator at findahealthcenter.hrsa.gov or by calling 1-877-464-4772.
If you are a veteran — including any veteran with a history of Agent Orange, burn pit, or toxic substance exposure — contact the VA at 1-800-827-1000 to establish healthcare eligibility. Many veterans who do not know they qualify for VA health care are actually eligible under expanded exposure-related coverage laws.
If you are not a veteran and have no access to an FQHC, call the American Cancer Society at 1-800-227-2345 (24/7) and explain your situation. ACS navigators specifically help uninsured men find free screening options including community health fairs, free clinic events, and state health department programs by ZIP code. ZERO Cancer’s helpline (1-844-244-1309) can also search their national database for free testing events near you.
Additionally, your state health department may operate a cancer screening program for low-income uninsured residents — NJ CEED is one example, but most states have equivalent programs. Call your county health department and ask specifically about free men’s health or prostate cancer screening.
Early prostate cancer typically has no symptoms at all. This is precisely why screening matters — early-stage prostate cancer is often entirely asymptomatic, meaning men feel completely normal while the cancer is still small and most treatable. Waiting for symptoms before getting tested means waiting until the disease has often progressed.
Symptoms that can be associated with prostate conditions — though more often caused by a benign enlarged prostate (BPH) than by cancer — include: frequent urination, especially at night; difficulty starting or stopping urination; weak or interrupted urine flow; burning or pain during urination; blood in urine or semen; painful ejaculation; or persistent lower back, hip, or pelvic pain.
These symptoms warrant a medical visit, but their absence does not mean your prostate is healthy. The goal of PSA screening is to find prostate cancer before these symptoms appear — when it is still localized, when the five-year survival rate is 97.9 percent, and when treatment options are most effective and least disruptive. If you are experiencing any of these symptoms, contact your physician promptly rather than waiting for a free screening event.
A first-degree family history — father or brother diagnosed with prostate cancer — significantly elevates your risk and changes the recommended screening timeline. The AUA’s 2026 guidelines classify men with a strong family history of prostate cancer (father, brother, or multiple relatives) as high-risk, alongside Black men and those with identified germline mutations (such as BRCA1, BRCA2, or Lynch syndrome genes).
For high-risk men, the AUA now recommends beginning PSA discussions with your physician between ages 40 and 45 — compared to ages 45 to 50 for average-risk men. If your father was diagnosed at a younger age (before 65), consider starting the conversation even earlier, in your late 30s to early 40s.
A family history also strengthens the case for genetic counseling to determine whether you carry inheritable mutations that further elevate your risk. The Prostate Cancer Foundation and major cancer centers offer guidance on genetic testing. Men with BRCA2 mutations have significantly elevated prostate cancer risk — this information affects both your own screening plan and potentially your children’s health planning.
Sources: AUA Early Detection of Prostate Cancer Guideline 2026 (age-adjusted PSA ranges; repeat before biopsy; mpMRI; percent free PSA; high-risk screening at 40-45; BRCA2). USPSTF (screening recommendation ages 55-69; against 70+; reassessment underway). AARP Nov 2025 (USPSTF reassessment; Medicare no age limit). NCI / cancer.gov (early prostate cancer asymptomatic; symptom list). PubMed PLCO trial (percent free PSA improved fatal prostate cancer prediction). StatPearls / NCBI 2026 (PSA elevation causes; finasteride suppression; pre-test instructions). HRSA.gov (findahealthcenter.hrsa.gov; FQHC eligibility). PCF.org (germline mutations; family history guidance). BudgetSeniors.com Mar 2026 (editorial synthesis; uninsured access pathways).
Allow location access when prompted for the most accurate results near your home. These buttons search for free and low-cost prostate testing locations and related healthcare resources in your area.
- If you are 50 or older and have Medicare: Ask your primary care doctor to order your annual free PSA blood test at your next appointment. Confirm your doctor accepts Medicare assignment. This is your right at no cost.
- If you are a veteran: Call 1-800-827-1000 to confirm your VA enrollment status and request a prostate screening. If you had Agent Orange or toxic substance exposure, you are likely eligible regardless of other factors.
- If you are 40–45 and Black, or have a father or brother with prostate cancer: Begin the PSA discussion with your physician now — not at 50. The AUA’s 2026 guidelines specifically recommend earlier screening for high-risk men.
- If you are uninsured and under 50: Visit findahealthcenter.hrsa.gov or call the ACS at 1-800-227-2345 to locate free PSA testing in your community.
- Before your test: No ejaculation for 48 hours. No vigorous cycling or perineal exercise for 48 hours. No DRE for 1 week. Disclose all medications to your doctor — especially finasteride or dutasteride.
- If your PSA comes back elevated: Do not panic. Request a repeat test first. Discuss percent free PSA and other biomarker options with your urologist before agreeing to a biopsy. One elevated number is not a diagnosis.
This guide is for informational and resource-referral purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Decisions about PSA testing — including whether to be tested, how to interpret results, and whether to pursue further evaluation — should be made in consultation with a licensed physician familiar with your complete medical history. If you are experiencing urinary symptoms or other prostate health concerns, seek medical evaluation promptly rather than waiting for a free community screening event. © BudgetSeniors.com — Verified health resource information for older adults and their families.
Sources: All contact information, eligibility requirements, program details, and medical statistics verified from official sources in March 2026 including: AUA.org Early Detection Guideline 2026; Medicare.gov; VA.gov / cancer.va.gov; HRSA.gov; zerocancer.org; pcf.org; cancer.org; NCI cancer.gov; USPSTF.org; NCBI StatPearls 2026; PubMed PLCO trial; PMC community screening study; NBC4 Washington Sept 2025; AARP Nov 2025. © BudgetSeniors.com. Not a substitute for medical care or physician consultation.